These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 9564988

  • 21. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF, Roberts CS, de Caprariis PJ, Reisman A.
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992 Dec; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 24. High prevalence of antibiotic resistance in isolates from the middle meatus of children and adults with acute rhinosinusitis.
    Huang WH, Fang SY.
    Am J Rhinol; 2004 Dec; 18(6):387-91. PubMed ID: 15706987
    [Abstract] [Full Text] [Related]

  • 25. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 26. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
    Tarshis GA, Miskin BM, Jones TM, Champlin J, Wingert KJ, Breen JD, Brown MJ.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Staphylococcus aureus: is it a pathogen of acute bacterial sinusitis in children and adults?
    Wald ER.
    Clin Infect Dis; 2012 Mar; 54(6):826-31. PubMed ID: 22198792
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M, Peterson J, Fisher AC, Qin Z, Nicholson SC, Kahn JB.
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [Abstract] [Full Text] [Related]

  • 30. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
    Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL.
    Diagn Microbiol Infect Dis; 2008 May; 61(1):13-20. PubMed ID: 18313879
    [Abstract] [Full Text] [Related]

  • 31. Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.
    Sher LD, Poole MD, Von Seggern K, Wikler MA, Nicholson SC, Pankey GA.
    Otolaryngol Head Neck Surg; 2002 Sep; 127(3):182-9. PubMed ID: 12297808
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults.
    Adelglass J, DeAbate CA, McElvaine P, Fowler CL, LoCocco J, Campbell T.
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):320-7. PubMed ID: 10064632
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis].
    Li XP, Qin ZM, Zheng RH, Tan QL, Zhou YY, Zhu L, Yin AF.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 14(12):573-5. PubMed ID: 12563960
    [Abstract] [Full Text] [Related]

  • 34. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 35. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Cazzola M, Vinciguerra A, Di Perna F, Califano C, Calderaro F, Salzillo A, Centanni S.
    J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group.
    Lasko B, Lau CY, Saint-Pierre C, Reddington JL, Martel A, Anstey RJ.
    J Int Med Res; 1998 Dec; 26(6):281-91. PubMed ID: 10399110
    [Abstract] [Full Text] [Related]

  • 38. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
    Trinchieri A, Marchetti F.
    Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
    [Abstract] [Full Text] [Related]

  • 39. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 40. [Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains].
    Sugita R, Deguchi K, Fujimaki Y, Harada S, Shimizu K, Kimura S, Watanabe H, Komatsu N, Okano K, Naito M, Nomura T, Tanaka M, Yoshida Y, Tanaka H, Iwai N, Nakamura H.
    Jpn J Antibiot; 1997 Aug; 50(8):727-37. PubMed ID: 9339399
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.